TIGIT: A promising target to overcome the barrier of immunotherapy in hematological malignancies

Immune evasion through up-regulating checkpoint inhibitory receptors on T cells plays an essential role in tumor initiation and progression. Therefore, immunotherapy, including immune checkpoint inhibitor targeting programmed cell death protein 1 (PD-1) and chimeric antigen receptor T cell (CAR-T) t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Shenhe, Zhang, Ye, Zhou, Fengping, Chen, Xiaochang, Sheng, Jianpeng, Zhang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807865/
https://www.ncbi.nlm.nih.gov/pubmed/36605439
http://dx.doi.org/10.3389/fonc.2022.1091782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807865/
https://www.ncbi.nlm.nih.gov/pubmed/36605439
http://dx.doi.org/10.3389/fonc.2022.1091782

Ejemplares similares